Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening

Journal of Cystic Fibrosis

Volumn 14, Issue 6, 2015, Pages 706-713

  Munck, A ^a,b   Mayell, S J ^c   Winters, V ^d   Shawcross, A ^c   Derichs, N ^e   Parad, R ^f,g   Barben, J ^h   Southern, K W ^c,d  

^a Association Française Pour Le Depistage et la Prevention des Handicaps de l'Enfant   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h Children's Hospital   (Switzerland)

Author keywords

CFSPID; CRMS; Cystic fibrosis; Newborn screening

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; INFLUENZA VACCINE; SWEAT CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; CROSS INFECTION; CYSTIC FIBROSIS; CYSTIC FIBROSIS SCREEN POSITIVE INCONCLUSIVE DIAGNOSIS; DELPHI STUDY; DIAGNOSTIC PROCEDURE; DIETARY INTAKE; FOLLOW UP; GENE MUTATION; HUMAN; INFANT; INFLUENZA VACCINATION; NEWBORN SCREENING; SALT INTAKE; SENSITIVITY ANALYSIS; NEWBORN; PRACTICE GUIDELINE;

CYSTIC FIBROSIS; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING;

EID: 84930160557     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.01.001     Document Type: Article

References (13)

1. Farrell P.M. Is newborn screening for cystic fibrosis a basic human right?. J Cyst Fibros 2008, 7:262-265.
2. Castellani C., Southern K.W., Brownlee K., Dankert Roelse J., Duff A., Farrell M., et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009, 8:153-173.
3. Southern K.W., Munck A., Pollitt R., Travert G., Zanolla L., Dankert-Roelse J., et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007, 6:57-65.
4. Mayell S.J., Munck A., Craig J.V., Sermet I., Brownlee K.G., Schwarz M.J., et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009, 8:71-78.
5. Borowitz D., Parad R.B., Sharp J.K., Sabadosa K.A., Robinson K.A., Rock M.J., et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009, 155:S106-S116.
6. Nelson M.R., Adamski C.R., Tluczek A. Clinical practices for intermediate sweat tests following abnormal cystic fibrosis newborn screens. J Cyst Fibros 2011, 10:460-465.
7. Ren C.L., Desai H., Platt M., Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol 2011, 46:1079-1084.
8. Scotet V., Audrezet M.P., Roussey M., Rault G., Dirou-Prigent A., Journel H., et al. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?. Pediatrics 2006, 118:e1523-e1529.
9. Thauvin-Robinet C., Munck A., Huet F., Genin E., Bellis G., Gautier E., et al. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening. J Med Genet 2009, 46(11):752-758.
10. Peckham D., Conway S.P., Morton A., Jones A., Webb K. Delayed diagnosis of cystic fibrosis associated with R117H on a background of 7T polythymidine tract at intron 8. J Cyst Fibros 2006, 5:63-65.
11. Harold A. The Delphi method, techniques and applications 2002, New Jersey Institute of Technology, Linstone & Murray Turoff.
12. Goubau C., Wilschanski M., Skalická V., Lebecque P., Southern K.W., Sermet I., et al. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax Aug 2009, 64(8):683-691.
13. Bombieri C., Claustres M., De Boeck K., Derichs N., Dodge J., Girodon E., et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros Jun 2011, 10(Suppl. 2):S86-S102.